Study on Dosage Compensation in Human Cell Lines
Author Information
Author(s): Colette M Johnston, Frances L Lovell, Daniel A Leongamornlert, Barbara E Stranger, Emmanouil T Dermitzakis, Mark T Ross
Primary Institution: Wellcome Trust Sanger Institute
Hypothesis
How does escape from X chromosome inactivation affect dosage compensation in human cell lines?
Conclusion
Dosage compensation in human lymphoblastoid cell lines is virtually complete, with only a small proportion of X-linked genes escaping inactivation.
Supporting Evidence
- Overall expression from the X chromosome is only slightly higher in females.
- Only 5.4% of X-linked genes showed significantly higher expression in females.
- Dosage compensation is achieved effectively in human lymphoblastoid cell lines.
Takeaway
This study looked at how genes on the X chromosome are expressed in males and females. It found that the differences are very small, meaning that both sexes have similar levels of gene activity.
Methodology
Gene expression was analyzed using microarrays from lymphoblastoid cell lines of 210 individuals across four populations.
Potential Biases
Potential for inter-individual variability in gene expression that could affect results.
Limitations
The study focused only on lymphoblastoid cell lines, which may not represent other tissues.
Participant Demographics
210 unrelated individuals from four populations: CEU, CHB, JPT, and YRI.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website